Pharmaceutical

Advent International and Essex Woodlands fully exited Brazilian pharmaceutical company Biotoscana through a strategic sale to Canadian pharmaceutical company Knight Therapeutics. Advent and Essex Woodlands ‘s 51% stake was purchased…

Caisse de dépôt et placement du Québec (CDPQ) acquired a minority stake in Mexican pharmaceutical company Sanfer for US$500m. General Atlantic will maintain its minority stake in Sanfer and work…

Brazilian pharmaceutical company Eurofarma launched Axon Ventures, a R$45m early-stage CVC fund. (Baguete) A Eurofarma, farmacêutica brasileira presente em 20 países, vai investir em projetos de tecnologia focados no setor…

Brazil’s Eurofarma launched Axon Ventures, a US$12m CVC fund to invest in early-stage healthcare startups in Brazil. Eurofarma’s head of corporate venture, Paulo Braga, will lead the effort. (Crunchbase) Brazilian pharmaceutical giant Eurofarma…

ACON Investments in partnership with Humus Capital Partners have acquired a majority stake in Biosidus S.A. and Biosidus Farma S.A. (collectively, “Biosidus”), Argentina’s largest manufacturer and distributor of biosimilar pharmaceuticals.

Advent International has partially exited Uruguay-based pharmaceutical company Biotoscana through an initial public offering of Brazilian Depositary Shares (BDRs) on Brazil’s B3 stock exchange. (Valor Econômico) A oferta pública inicial…

(Exame) General Atlantic is in negotiations to buy a minority stake in pharmacy network, Pague Menos. With 800 stores and R4.4b turnover, Pague Menos should be valued at R$3.5b. American…

(Press Release) Genomma Lab International entered into an agreement to sell majority participation in Grupo Comercial y Industrial Marzam to Duth private equity firm, Moench Coöperatief. Genomma Lab Announces Sale…

(Press Release) Pharma Major Lupin Limited announced the acquisition of 100% equity stake in Medquimica Industria Farmaceutica S.A., Brazi subject to certain closing conditions. Graycliff Partners Exits Medquímica in Sale…

(Press Release) ALL Ventures Partners announced a Series A investment of US$3.33m in Mexican speciality pharmacy, Farmacias Personalizadas. ALL Venture Partners Invests in Farmacias Personalizadas was last modified: May 29th,…